We are Sorry, This Page doesn't Exist
Cassava stock falls on failed Alzheimer"s study
Shares of Cassava Sciences Inc. tumbled 73.2% in trading on Friday after the company said its investigational Alzheimer's disease treatment failed a mid-.....»»
Why AbbVie"s Stock Is Trading Higher Today
AbbVie (NYSE: ABBV) shares are trading higher on Monday. L.....»»
AbbVie Earnings: 5 Things for ABBV Stock Investors to Know About Q1
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AbbVie (ABBV) earnings f.....»»
AbbVie Analyst Upgrades Stock To Outperform, Looks Forward To 2021
AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at RBC Capital Markets. .....»»
Why This Late-Stage Kidney Cancer Study Could Be Huge
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study......»»
The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio Diagnostics Inc (NASDAQ: CEMI) Cytosorbents Corp (N.....»»
Why Immunomedics Stock More Than Doubled
Immunomedics shares soared on Monday after the announcements that a late-stage breast cancer study was halted early and a new chief executive officer was named......»»
Jim Cramer Gives His Opinion On AbbVie, Domino"s Pizza And More
Jim Cramer said on CNBC's "Mad Money Lightning Round" AbbVie Inc (NYSE: ABBV) traded lower on COVID-19, but he likes its dividend yield and it remains a great stock. read more.....»»
Loss widens – and stock falls – at St. Louis-based building supplier
Huttig Building Products Inc.'s stock fell Monday on weak results. The St. Louis-based distributor of building material for residential construction said sales in 2019 totaled $812 million, off 3% from 2018. The company's yearly loss widened to $21.3 .....»»
April 9th Options Now Available For AbbVie (ABBV)
Stock Options Channel.....»»
Lilly"s stock falls on failed Alzheimer"s study
Shares of Eli Lilly and Co. fell 4% in premarket trading on Monday after solanezumab, the experimental therapy it was testing in people with a form .....»»
AbbVie Earnings: ABBV Stock Jumps More Than 6% on Q4 Beats
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AbbVie (ABBV) earnings for the bi.....»»
US Stock Market Red on Friday
T-Mobile falls on 4th-quarter resultsRelated Stocks: TMUS, NOV, WYNN, ABBV, FDX, ATVI, JNPR, TTWO, FTL, ALB, ABMD,.....»»
Kellogg stock falls after weak guidance
Kellogg Co. shares fell nearly 7% in Thursday pr.....»»
Peloton stock falls 10% after earnings, weak third-quarter revenue guidance
Peloton Interactive Inc. fell more than 10% in extended trading after the company beat consensus estimates but issued guidance that was below fiscal third-quarter expectations......»»
Xilinx stock falls more than 10% after weak fourth-quarter guidance, layoffs
Xilinx Inc. shares fell more than 10.9% in the extended session Tuesday after the company reported fourth-quarter guidance below consensus estimates but higher-than-expected third-quarter sales. The company report.....»»
Penny Stock Rips 260% Higher On Fast Track Designation For Experimental Lung Cancer Gene Therapy
Shares of thinly-traded gene therapy company Genprex Inc (NASDAQ: GNPX) are soaring on more than 50 times their average volume Tuesday. 0 read more.....»»
FDA Fast Track on Lung Cancer Treatment Brings Exponential Gains for This Microcap Stock
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from........»»
Portola"s stock falls on weak Andexxa sales
Shares of Portola Pharmaceuticals Inc. tumbled .....»»
One Analyst Thinks AbbVie Is Grossly Undervalued
The stock was static in 2019, but a Wall Street veteran thinks investors are overlooking the company's outstanding pipeline and strong upward momentumRelated Stocks: LLY, GSK, SNY, AZN, ABBV,.....»»